Fig. 1

Blistering disease in the context of COVID-19 vaccination. Erythematous, urticarial papules and confluent plaques with admixed vesicles and erosions on the torso and extremities before treatment (a) and 5 weeks after treatment (b) in case 1. Widely scattered crusted erosions and pink, scaly papules over upper thigh (c) in case 2. Superficial, crusted erosions on the posterior neck before treatment (d) and 6 weeks after treatment (e) in case 3